Cytokine Profile & Metal Ion Concentrations at Patients NCT00289679

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Recruiting

Study information
Verified date	July 2007
Source	Frederiksberg University Hospital
Contact	arne borgwardt, md
Phone	004538163450
Email	arne[@]borgwardt.com
Is FDA regulated	No
Health authority	Denmark: Ethics Committee
Study type	Interventional

To evaluate the concentration of cytokines and metal ions in blod samples and biopsies from patients undergoing a hip revision.

Recruitment information / eligibility
Status	Recruiting
Enrollment	0
Est. completion date
Est. primary completion date
Accepts healthy volunteers	No
Gender	Both
Age group	18 Years and older
Eligibility	Inclusion Criteria: - THR revision

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Device:
• Hip prosthesis revision

Locations
Country	Name	City	State
Denmark	Frederiksberg University Hospital	Frederiksberg

Sponsors *(1)*
Lead Sponsor	Collaborator
Frederiksberg University Hospital

Denmark,